Hyperlipidemia and mortality in patients on peritoneal dialysis

BACKGROUND: New lipid-lowering therapy at the start of dialysis and measurement of lipid parameters over the follow-up period is not recommended in dialysis patients, which seems unappropriated in clinical practice. We aimed to examine the effect of hyperlipidemia on mortality in patients undergoing...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xiaoran, Zhan, Xiaojiang, Wen, Yueqiang, Peng, FenFen, Wang, Xiaoyang, Wang, Niansong, Wu, Xianfeng, Wu, Junnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590170/
https://www.ncbi.nlm.nih.gov/pubmed/36280801
http://dx.doi.org/10.1186/s12882-022-02970-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590170/
https://www.ncbi.nlm.nih.gov/pubmed/36280801
http://dx.doi.org/10.1186/s12882-022-02970-w

Ejemplares similares